Form 4: Fennec Pharmaceuticals Director Sells Shares
Insider Transaction (Form 4)
Marco Maria Brughera, a Director of Fennec Pharmaceuticals Inc., sold 15,545 shares of common stock on September 15, 2026 for $10.29 per share.
Summary
- Option exercise/conversion: acquired 15,545 Common Shares at $2.11 ($32,800) on September 15, 2026; holds 15,545 after (Direct).
- Open-market sale: disposed of 15,545 Common Shares at $10.29 ($159,958) on September 15, 2026 (Direct).
- Option exercise/conversion: disposed of 15,545 Stock Option on September 15, 2026; holds 220,000 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $159,958 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Marco Maria Brughera — Director
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-15 | Option exercise/conversion | Common Shares | 15,545 | $2 | $32.8K | 15,545 |
| 2026-09-15 | Open-market sale | Common Shares | 15,545 | $10 | $160.0K | 0 |
| 2026-09-15 | Option exercise/conversion | Stock Option | 15,545 | — | — | 220,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-15 | Option exercise/conversion (15,545 shares) |
| 2026-09-15 | Open-market sale (15,545 shares) |
| 2026-09-15 | Option exercise/conversion (15,545 shares) |
Keywords
insider transaction, Form 4, FENC, FENNEC PHARMACEUTICALS INC., bearish, Marco Maria Brughera
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.